CA 15-3 - Serum

CA 15-3 is a laboratory test used to evaluate the requested biomarker or biological characteristic in the submitted specimen. The service is designed for cancer diagnosis support, molecular classification, prognosis, treatment-selection support and disease monitoring. In this listing, the submitted material is Serum, and the laboratory is expected to select or confirm a validated procedure that is technically suitable for that matrix. A typical technical approach is Validated laboratory method appropriate to the measurand, matrix and applicable standard. The exact instrument, standard, extraction, digestion, calibration model, culture condition, reagent system or specimen-processing step may differ according to the receiving laboratory's validated scope. Where an ASTM, ISO, IEC, EPA, FDA, pharmacopeial, clinical, customer or in-house method is mandatory, that requirement should be stated when the test is booked. The laboratory should also confirm that its working range, selectivity, detection capability and quality-control scheme are appropriate for the expected level of CA 15-3. Results produced outside a validated range may require dilution, repeat preparation, a different specimen quantity or a more sensitive method. Sample quality is especially important. Submit approximately 2–5 mL of Serum, unless the laboratory specifies a different minimum after reviewing the method. The sample should represent the batch, location, patient, product, process stream or experimental condition that the customer actually wants to evaluate. Where the material is heterogeneous, replicate increments or a documented composite may be more defensible than a single convenient grab sample. Contamination, evaporation, moisture change, degradation, microbial growth, inappropriate anticoagulant, adsorption to the container, or alteration during transport can create a result that is analytically precise but not representative of the original material. The final report should identify the sample, method or method family, result, units and any relevant reporting or quantification limit. For compliance work, the customer should provide the applicable specification so the laboratory can avoid making an unsupported pass/fail judgement. For research work, raw or supporting data may also be useful for statistical analysis, comparison across treatments or publication. For this exact catalogue entry, identify the request as “CA 15-3” and the matrix as “Serum”. If the project involves multiple samples, keep the naming scheme consistent so the result for one specimen cannot be confused with another. Tell the laboratory about known interferents, treatments, formulation ingredients, service history or unusual sample conditions that could affect Validated laboratory method appropriate to the measurand, matrix and applicable standard. The AnalysisAfrica listing should be used to arrange the test and sample logistics; the receiving laboratory remains responsible for confirming the final analytical procedure, sample acceptance and reportable scope. Catalogue quality-control reference AA-DESC-04914 distinguishes this description and its handling assumptions from other tests in the import set.